Svetinorm
- Category
- Bioregulators
- Administration routes
- Oral
- Regulatory status
- Not FDA-approved
What it is
Svetinorm is a liver-derived bioregulator peptide marketed to aid liver regeneration in hepatitis, chemo recovery, and general liver strain. Benefits remain unproven, despite an internal report describing human outcomes. It is not a substitute for medical treatment, and mild allergy to the material is possible. It is not FDA-approved; it is sold internationally as a dietary supplement, and unregulated products sold online vary in quality.
Read Full recordStudied uses & evidence
Studied uses(4)
Hepatoprotective effects in chronic hepatitis
SpeculativeAn internal human report studied Svetinorm; benefit remains uncertain.
Improved liver function markers (bilirubin, ALT reduction)
SpeculativeAn internal human report includes bilirubin and ALT measurements; efficacy remains unconfirmed.
Post-chemotherapy liver recovery support
SpeculativeAn internal report includes 13 post-chemotherapy patients; benefit remains uncertain.
Evidence limits
- Evidence Level
- Limited Evidence
Svetinorm has a formal clinical study from the Khavinson Institute testing 47 patients against 38 controls, which is among the better-documented bioregulator studies. Results showed hepatoprotective effects in chronic hepatitis and post-chemotherapy patients with improvements in both subjective symptoms and biochemical markers. However, the study was open-label, conducted at a single center, and has not been replicated outside Russia.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(2)
Risks = level of concern: High · Moderate · Low · Theoretical
Allergic reaction to bovine liver-derived peptides
LowNot a substitute for medical liver treatment
High
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.